VICOR CORP 10-Q Summary: Period Ended June 30, 2005
Business Context and Reporting Period
This is a quarterly report (Form 10-Q) for VICOR CORPORATION for the three and six months ended June 30, 2005. The company designs and manufactures power supply products and technologies. The financial statements are unaudited.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2005 | Six Months Ended June 30, 2005 |
|---|---|---|
| Net Revenues | $44.6 million | $87.8 million |
| Gross Margin | $15.6 million (34.9%) | $32.6 million (37.2%) |
| Net Income | $0.1 million | $0.1 million |
| Diluted EPS | $0.00 | $0.00 |
| Cash and Equivalents | $55.4 million (as of June 30, 2005) | |
| Short-term Investments | $64.3 million (as of June 30, 2005) | |
| Working Capital | $146.9 million | |
| Current Ratio | 6.8:1 |
Material Changes vs. Prior Period
- Revenue: Q2 2005 revenue decreased 1.8% year-over-year to $44.6 million due to lower unit shipments. Six-month revenue was flat (down 0.2%) compared to the prior year.
- Gross Margin: Q2 gross margin percentage dropped to 34.9% from 38.3% in Q2 2004. This decline was driven by revenue decreases and increased inventory reserves.
- Inventory Reserves: The company recorded approximately $2.8 million in additional inventory reserves in the first half of 2005. This included $1.6 million related to the EU RoHS initiative and product platform conversions, and $1.2 million for slow-moving inventory.
- Operating Expenses: SG&A expenses decreased due to lower legal fees (following a 2004 settlement with Exar). R&D expenses increased 13.5% in Q2 and 16.3% for the six months, driven by development of Factorized Power Architecture (FPA) products.
- Legal Settlement: A $2.5 million settlement was received from Lambda Americas, Inc. regarding patent claims. Net of fees, a $2.25 million gain was recorded, significantly impacting operating income.
Outlook, Risks, and Unusual Items
- Unusual Items: The $2.25 million litigation gain is a non-recurring item. Without this gain, the company would have reported a net loss for the quarter.
- Capital Expenditures: Management authorized approximately $4.0 million for FPA equipment purchases for the remainder of 2005. Capital spending is expected to increase.
- Stock Repurchases: The company repurchased 312,700 shares for $3.3 million during the six-month period. Approximately $21.6 million remains available under the repurchase plan.
- Dividends: A cash dividend of $0.12 per share was declared, payable August 31, 2005.
- Accounting Changes: The company is evaluating the impact of FAS 123(R) regarding stock-based compensation, which will require fair value recognition starting January 1, 2006. This is expected to have a significant impact on future reported earnings.
- Risks: Ongoing patent litigation against Artesyn, Lucent, and Tyco remains pending. The outcome is uncertain, though recent court rulings affirmed patent validity while narrowing the scope of potential damages.
Investor Verification Checklist
- Inventory Valuation: Verify the adequacy of the $2.8 million in new inventory reserves, particularly regarding the RoHS initiative and V-I Chip pilot production.
- Recurring Earnings: Assess profitability excluding the $2.25 million one-time litigation gain to understand core operational performance.
- R&D Efficiency: Monitor the return on the increased R&D spend (up 16% YoY) related to the new FPA products.
- Legal Exposure: Track the status of the remaining patent infringement trials against Artesyn, Lucent, and Tyco.
- Future Expenses: Review the projected impact of FAS 123(R) adoption on 2006 net income.